Clinical Trials on CLDN18.2 Positive Solid Tumors in Germany
Total 220 results
-
Astellas Pharma Global Development, Inc.CompletedCLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction | CLDN18.2-positive Adenocarcinoma of Esophagus | CLDN18.2-positive Gastric AdenocarcinomaGermany, Latvia
-
Astellas Pharma Global Development, Inc.CompletedCLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction | CLDN18.2-positive Adenocarcinoma of Esophagus | CLDN18.2-positive Gastric AdenocarcinomaBulgaria, Czechia, Germany, Latvia, Russian Federation, Ukraine
-
Krankenhaus NordwestTerminatedHer2/Neu Positive Advanced Solid TumorsGermany
-
Immatics US, Inc.CompletedCancer | Solid Tumor | Refractory Solid Tumors | Recurrent Solid TumorsUnited States, Germany
-
Eli Lilly and CompanyCompletedSolid Tumor | Malignant Solid Tumor | Metastatic TumorGermany, United States, France
-
Merck KGaA, Darmstadt, GermanyCompleted
-
University of CologneBoehringer IngelheimCompleted
-
Silence Therapeutics GmbHCompleted
-
Glycotope GmbHCompleted
-
Ganymed Pharmaceuticals GmbHCompletedSolid TumorsGermany, Latvia
-
PfizerCompletedNeoplasms | Solid TumorsNetherlands, Germany
-
Glycotope GmbHGlycotope Biotechnology GmbHCompleted
-
BayerCompleted
-
University Hospital, EssenCompleted
-
Merck KGaA, Darmstadt, GermanyThreshold PharmaceuticalsCompleted
-
Philogen S.p.A.RecruitingAdvanced Solid Tumor | Metastatic Solid TumorItaly, Germany, Switzerland
-
Hoffmann-La RocheRecruitingALK Fusion-positive Solid or CNS TumorsUnited States, Korea, Republic of, China, Spain, Canada, Australia, United Kingdom, Denmark, France, Italy, Germany, Brazil
-
University Hospital HeidelbergGerman Cancer Research CenterRecruitingSolid Tumor | CNS TumorFrance, Germany, Australia, Austria, Sweden, Netherlands, Switzerland
-
Pieris Pharmaceuticals GmbHFGK Clinical Research GmbHCompleted
-
Merck KGaA, Darmstadt, GermanyCompletedSolid TumorsGermany
-
Boehringer IngelheimCompletedMalignant Solid TumourGermany
-
Novartis PharmaceuticalsCompletedSolid TumorsSpain, Canada, France, Denmark, Netherlands, Germany, Norway
-
Eli Lilly and CompanyActive, not recruitingRelapsed Solid Tumor | Refractory Solid TumorUnited States, Canada, France, Australia, Belgium, Germany, Spain, Italy
-
European Organisation for Research and Treatment...CompletedUnspecified Adult Solid Tumor, Protocol SpecificNorway, Germany
-
Glycotope GmbHCompletedSolid Tumor, AdultGermany, Italy, Spain
-
Hoffmann-La RocheCompletedSolid TumorsHungary, United States, Korea, Republic of, Belgium, Germany, United Kingdom
-
BayerActive, not recruitingSolid TumorsUnited States, Germany, Japan, Denmark
-
T-knife GmbHTerminatedAdvanced Solid TumorsGermany, Belgium, Spain, Netherlands, United Kingdom
-
Glycotope GmbHCompleted
-
CatalYm GmbHRecruitingSolid Tumor, AdultSpain, Germany, Switzerland
-
Astellas Pharma Global Development, Inc.CompletedAdvanced Solid TumorsGermany, Czechia, United States, Brazil, Poland, Singapore, Thailand
-
Hoffmann-La RocheCompletedSolid TumorsUnited States, Spain, Germany, France, Israel, Italy, United Kingdom
-
Boehringer IngelheimActive, not recruitingSolid Tumors, KRAS Mutation; SOS1United States, Netherlands, Germany
-
Ganymed Pharmaceuticals GmbHCompletedSolid TumorsGermany, Switzerland, Latvia, Bulgaria, Lithuania
-
European Organisation for Research and Treatment...CompletedUnspecified Adult Solid Tumor, Protocol SpecificFrance, Germany
-
University Hospital HeidelbergGerman Cancer Research CenterRecruitingSolid Tumor, AdultGermany
-
Merck Sharp & Dohme LLCTerminatedAdvanced Solid TumorsGermany, Spain, United Kingdom
-
Boehringer IngelheimRecruitingSolid TumorsUnited States, Spain, Germany, Austria, France, Belgium
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedAdvanced Solid TumorsUnited States, Germany, Norway, Netherlands, Belgium, Denmark, Sweden, Switzerland
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors | Metastatic Solid TumorsFrance, Netherlands, Spain, Canada, Singapore, Germany, Korea, Republic of, Australia, Belgium, Switzerland, Italy, United States
-
Eisai Inc.Merck Sharp & Dohme LLCCompletedSolid TumorsUnited States, China, Belgium, Australia, Italy, Korea, Republic of, Germany, Netherlands, Poland, Romania, Thailand
-
PfizerCompletedSolid TumorsUnited States, Taiwan, Japan, Korea, Republic of, Russian Federation, Hungary, France, Czechia, Germany, Italy, United Kingdom
-
European Organisation for Research and Treatment...CompletedUnspecified Adult Solid Tumor, Protocol SpecificGermany, France
-
Bristol-Myers SquibbCompletedSolid TumorsUnited States, Australia, Spain, Germany, France, Switzerland, Netherlands, Canada, Belgium, Italy
-
Hoffmann-La RocheCompletedSolid TumorsUnited States, Korea, Republic of, Australia, Canada, Germany, Singapore
-
Vall d'Hebron Institute of OncologyTaisho Pharmaceutical Co., Ltd.; Roche Pharma AG; Iqvia Pty Ltd; Janssen, LPRecruitingAdvanced Solid TumorSpain, France, Germany, Netherlands, Sweden, United Kingdom, Italy
-
AmgenCompletedAdvanced Solid TumorsBelgium, Canada, Australia, United States, Spain, Poland, France, Germany, Japan, United Kingdom
-
AmgenRecruitingAdvanced Solid TumorsUnited States, Korea, Republic of, Spain, Australia, Germany, France, Japan, Canada
-
Merck Sharp & Dohme LLCTerminatedAdvanced Solid TumorsFrance, Germany, Spain, United Kingdom
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.TerminatedHER2 Expressing Solid TumoursUnited States, Germany